• OPEN AN ACCOUNT
Indian Indices
Nifty
25,005.50 32.40
(0.13%)
Sensex
81,548.73 123.58
( 0.15%)
Bank Nifty
54,669.60 133.60
( 0.24%)
Nifty IT
36,003.50 -180.30
( -0.50%)
Global Indices
Nasdaq
46,125.99 614.06
(1.35%)
Dow Jones
6,607.70 54.66
(0.83%)
Hang Seng
44,333.89 496.22
(1.13%)
Nikkei 225
9,297.58 72.19
(0.78%)
Forex
USD-INR
88.14 0.12
(0.13%)
EUR-INR
103.49 0.19
(0.18%)
GBP-INR
119.43 0.38
(0.32%)
JPY-INR
0.60 0.00
(0.58%)

EQUITY - MARKET SCREENER

Bacil Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524516
INE711D01018
17.9843935
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
45.45
50.24
EPS(TTM)
Face Value()
Div & Yield %
0.77
10
0
 

Esha Media Research Ltd - Board Meeting Intimation for Prior Intimation Of Board Meeting Under Regulation 29(1) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ('Listing Regulations').
Sep 02,2025
Esha Media Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2025 inter alia to consider and approve Pursuant to Regulation 29 of Listing Regulations please note that the Meeting of the Board of Directors of M/s. Esha Media Research Limited is scheduled to be held on Friday 05th Day of September 2025 at Shorter Notice inter-alia: a) To take on record Secretarial Audit Report for the F.Y. 2024-25; b) To approve the Directors Report and related annexures for the F.Y. 2024-25; c) To fix the date of the 42nd Annual General Meeting (AGM) and approve draft notice of AGM and other incidental matters; We request you to take the above information on record and the same be treated as compliance under the applicable provision(s) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.